Viewing Study NCT00215735


Ignite Creation Date: 2025-12-24 @ 10:18 PM
Ignite Modification Date: 2025-12-25 @ 7:51 PM
Study NCT ID: NCT00215735
Status: TERMINATED
Last Update Posted: 2012-03-20
First Post: 2005-09-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Effect of Platelet Concentrate in Treatment of Diabetic Ulcers
Sponsor: Harvest Technologies
Organization:

Study Overview

Official Title: Clinical Evaluation of the Safety and Effectiveness of Harvest Autologous Platelet Concentrate and Autologous Thrombin for Treatment of Lower Extremity Chronic Diabetic Ulcers
Status: TERMINATED
Status Verified Date: 2012-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: inconclusive results, market feasiblity
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Autologous platelet concentrate will enhance the rate of healing of chronic diabetic wounds
Detailed Description: The treatment of a diabetic wound with APC and thrombinhas the potential to accelerate the re-epithial process when compared with usual care. The study is a prospective, randomized, blinded, multicenter clinical evaluation.

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: